Thanks to srin for this update:
* KN secured a Product Trial at Walmart's Online Store, sales volume will decide if ActiPatch is brought into the brick & mortar stores, 7/10 Interview,
http://www.bielcorp.com/the-stock-day-podcast...pioid-use/
* "We are finalizing product packaging configuration, pricing, and reimbursement coding with the largest distributor of chiropractic products in US. They have access to 80% of the 70,000 chiropractors in the US who treat 35 million patients annually. " 8/19/2019 and 9/3/2019 Shareholder Update
* "We had the opportunity to introduce and explain our devices unique features to the senior management of a new significant customer. The presentation went very well, and we anticipate several new sales channels to open." 9/3/2019 Shareholder Update
* "Our products have been cleared for market in the United Arab Emirates. We have the initial order." 9/3/2019 Shareholder Update, Q3 revenue with access to a new country for BIEL
* On 6/28/2019 RecoveryRx received FDA 510k Clearance to treat Post-Op Pain. BIEL is currently securing Partners to service the large Surgery Market (15 million US ) and the Chronic Wound Market ( 7 million US ). https://www.accessdata.fda.gov/scripts/cdrh/c...ID=K190251
* "We remain in discussions with several marketers of wraps and braces for the sports and retail markets." 8/19/2019 Shareholder Update
* "We are in contract negotiations with a sales and marketing partner in the foot care market. We are also meeting and discussing sales and marketing opportunities with several US consumer goods providers." 8/19/2019 Shareholder Update
* "We have entered into a License and Supply Agreement with a US manufacturer of wraps and braces to include our devices in their private label knee sleeves, back wraps, and wrists, ankle and elbow supports. Their products are sold to US physical therapist, chiropractors, orthopedic physicians and other health care professionals.The inclusion of our ActiPatch devices gives the seller the distinct advantage of being able to make specific medical claims for the treatment of pain." 8/2/2019 Shareholder Update
* "We are in an active, collaborative design phase with a leading foot care company for the redesigned plantar fasciitis (heel pain) product, which is already FDA approved. Since podiatric applications include the knee, BioElectronics is in discussions with the same company to include the new knee sleeve ActiPatch in their product line for knee pain. We anticipate getting the product on to the shelves of major retailers in 2020." 8/2/2019 Shareholder Update
* ActiPatch Full Body FDA Clearance …. Submitted 8/19/2019, Full Body Clearance makes ActiPatch more attractive to Partners/Licensees/Distributors
* KN secured a Product Trial at Walmart's Online Store, sales volume will decide if ActiPatch is brought into the brick & mortar stores, 7/10 Interview,
http://www.bielcorp.com/the-stock-day-podcast...pioid-use/
* "We are finalizing product packaging configuration, pricing, and reimbursement coding with the largest distributor of chiropractic products in US. They have access to 80% of the 70,000 chiropractors in the US who treat 35 million patients annually. " 8/19/2019 and 9/3/2019 Shareholder Update
* "We had the opportunity to introduce and explain our devices unique features to the senior management of a new significant customer. The presentation went very well, and we anticipate several new sales channels to open." 9/3/2019 Shareholder Update
* "Our products have been cleared for market in the United Arab Emirates. We have the initial order." 9/3/2019 Shareholder Update, Q3 revenue with access to a new country for BIEL
* On 6/28/2019 RecoveryRx received FDA 510k Clearance to treat Post-Op Pain. BIEL is currently securing Partners to service the large Surgery Market (15 million US ) and the Chronic Wound Market ( 7 million US ). https://www.accessdata.fda.gov/scripts/cdrh/c...ID=K190251
* "We remain in discussions with several marketers of wraps and braces for the sports and retail markets." 8/19/2019 Shareholder Update
* "We are in contract negotiations with a sales and marketing partner in the foot care market. We are also meeting and discussing sales and marketing opportunities with several US consumer goods providers." 8/19/2019 Shareholder Update
* "We have entered into a License and Supply Agreement with a US manufacturer of wraps and braces to include our devices in their private label knee sleeves, back wraps, and wrists, ankle and elbow supports. Their products are sold to US physical therapist, chiropractors, orthopedic physicians and other health care professionals.The inclusion of our ActiPatch devices gives the seller the distinct advantage of being able to make specific medical claims for the treatment of pain." 8/2/2019 Shareholder Update
* "We are in an active, collaborative design phase with a leading foot care company for the redesigned plantar fasciitis (heel pain) product, which is already FDA approved. Since podiatric applications include the knee, BioElectronics is in discussions with the same company to include the new knee sleeve ActiPatch in their product line for knee pain. We anticipate getting the product on to the shelves of major retailers in 2020." 8/2/2019 Shareholder Update
* ActiPatch Full Body FDA Clearance …. Submitted 8/19/2019, Full Body Clearance makes ActiPatch more attractive to Partners/Licensees/Distributors
1
